The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review
Abstract
:Simple Summary
Abstract
1. Introduction
2. The Form and Function of m6A
3. Key Genetic Players in Hepatoblastoma
4. The Impact of m6A on Tissue Development
5. Promotion of Hepatoblastoma via the m6A Pathway
6. The Role of m6A Associated Genes as Diagnostic and Prognostic Biomarkers
7. Detection of RNA Modification by Nanopore Sequencing
8. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Marin, J.J.G.; Cives-Losada, C.; Asensio, M.; Lozano, E.; Briz, O.; Macias, R.I.R. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers 2019, 11, 407. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morgan Auld, F.; Sergi, C.M. Surgical Pathology Diagnostic Pitfalls of Hepatoblastoma. Int. J. Surg. Pathol. 2022, 10668969211070178. [Google Scholar] [CrossRef] [PubMed]
- Lachance, E.; Mandziuk, J.; Sergi, C.M.; Bateman, J.; Low, G. Radiologic-Pathologic Correlation of Liver Tumors. In Liver Cancer; Sergi, C.M., Ed.; Exon Publications: Brisbane, QLD, Australia, 2021. [Google Scholar]
- Hager, J.; Sergi, C.M. Hepatoblastoma. In Liver Cancer; Sergi, C.M., Ed.; Exon Publications: Brisbane, QLD, Australia, 2021. [Google Scholar]
- Sergi, C.; Adam, S.; Kahl, P.; Otto, H.F. The remodeling of the primitive human biliary system. Early Hum. Dev. 2000, 58, 167–178. [Google Scholar] [CrossRef]
- Ranganathan, S.; Lopez-Terrada, D.; Alaggio, R. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr. Dev. Pathol. 2020, 23, 79–95. [Google Scholar] [CrossRef]
- Zhuo, Z.J.; Hua, R.X.; Chen, Z.; Zhu, J.; Wang, M.; Yang, Z.; Zhang, J.; Li, Y.; Li, L.; Li, S.; et al. WTAP Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study. Mol. Ther. Oncolytics 2020, 18, 118–125. [Google Scholar] [CrossRef]
- Jiang, X.; Liu, B.; Nie, Z.; Duan, L.; Xiong, Q.; Jin, Z.; Yang, C.; Chen, Y. The role of m6A modification in the biological functions and diseases. Signal. Transduct. Target Ther. 2021, 6, 74. [Google Scholar] [CrossRef]
- He, S.; Wang, H.; Liu, R.; He, M.; Che, T.; Jin, L.; Deng, L.; Tian, S.; Li, Y.; Lu, H.; et al. mRNA N6-methyladenosine methylation of postnatal liver development in pig. PLoS ONE 2017, 12, e0173421. [Google Scholar] [CrossRef]
- Sun, T.; Wu, R.; Ming, L. The role of m6A RNA methylation in cancer. Biomed. Pharmacother. 2019, 112, 108613. [Google Scholar] [CrossRef]
- Zhao, Y.; Peng, H. The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies. Cancers 2022, 14, 332. [Google Scholar] [CrossRef]
- Liu, L.; Wang, J.; Sun, G.; Wu, Q.; Ma, J.; Zhang, X.; Huang, N.; Bian, Z.; Gu, S.; Xu, M.; et al. m(6)A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma. Mol. Cancer 2019, 18, 188. [Google Scholar] [CrossRef] [Green Version]
- Cui, X.; Wang, Z.; Li, J.; Zhu, J.; Ren, Z.; Zhang, D.; Zhao, W.; Fan, Y.; Zhang, D.; Sun, R. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/beta-catenin signalling pathway. Cell Prolif. 2020, 53, e12768. [Google Scholar] [CrossRef] [Green Version]
- Li, G.; Deng, L.; Huang, N.; Cui, Z.; Wu, Q.; Ma, J.; Pan, Q.; Sun, F. m(6)A mRNA Methylation Regulates LKB1 to Promote Autophagy of Hepatoblastoma Cells through Upregulated Phosphorylation of AMPK. Genes 2021, 12, 1747. [Google Scholar] [CrossRef]
- Yang, C.; Hu, Y.; Zhou, B.; Bao, Y.; Li, Z.; Gong, C.; Yang, H.; Wang, S.; Xiao, Y. The role of m(6)A modification in physiology and disease. Cell Death Dis. 2020, 11, 960. [Google Scholar] [CrossRef]
- Huang, H.; Weng, H.; Chen, J. m(6)A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell 2020, 37, 270–288. [Google Scholar] [CrossRef]
- Zaccara, S.; Ries, R.J.; Jaffrey, S.R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 2019, 20, 608–624. [Google Scholar] [CrossRef]
- Liu, S.; Zhuo, L.; Wang, J.; Zhang, Q.; Li, Q.; Li, G.; Yan, L.; Jin, T.; Pan, T.; Sui, X.; et al. METTL3 plays multiple functions in biological processes. Am. J. Cancer Res. 2020, 10, 1631–1646. [Google Scholar]
- Lopez-Terrada, D.; Alaggio, R.; de Davila, M.T.; Czauderna, P.; Hiyama, E.; Katzenstein, H.; Leuschner, I.; Malogolowkin, M.; Meyers, R.; Ranganathan, S.; et al. Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium. Mod. Pathol. 2014, 27, 472–491. [Google Scholar] [CrossRef] [Green Version]
- Ignatova, V.V.; Stolz, P.; Kaiser, S.; Gustafsson, T.H.; Lastres, P.R.; Sanz-Moreno, A.; Cho, Y.L.; Amarie, O.V.; Aguilar-Pimentel, A.; Klein-Rodewald, T.; et al. The rRNA m(6)A methyltransferase METTL5 is involved in pluripotency and developmental programs. Genes Dev. 2020, 34, 715–729. [Google Scholar] [CrossRef]
- Chen, X.Y.; Zhang, J.; Zhu, J.S. The role of m(6)A RNA methylation in human cancer. Mol. Cancer 2019, 18, 103. [Google Scholar] [CrossRef] [Green Version]
- Esteve-Puig, R.; Bueno-Costa, A.; Esteller, M. Writers, readers and erasers of RNA modifications in cancer. Cancer Lett. 2020, 474, 127–137. [Google Scholar] [CrossRef]
- Mauer, J.; Luo, X.; Blanjoie, A.; Jiao, X.; Grozhik, A.V.; Patil, D.P.; Linder, B.; Pickering, B.F.; Vasseur, J.J.; Chen, Q.; et al. Reversible methylation of m(6)Am in the 5’ cap controls mRNA stability. Nature 2017, 541, 371–375. [Google Scholar] [CrossRef] [Green Version]
- Dominissini, D.; Moshitch-Moshkovitz, S.; Schwartz, S.; Salmon-Divon, M.; Ungar, L.; Osenberg, S.; Cesarkas, K.; Jacob-Hirsch, J.; Amariglio, N.; Kupiec, M.; et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 2012, 485, 201–206. [Google Scholar] [CrossRef]
- Moshitch-Moshkovitz, S.; Dominissini, D.; Rechavi, G. The epitranscriptome toolbox. Cell 2022, 185, 764–776. [Google Scholar] [CrossRef]
- Kortel, N.; Ruckle, C.; Zhou, Y.; Busch, A.; Hoch-Kraft, P.; Sutandy, F.X.R.; Haase, J.; Pradhan, M.; Musheev, M.; Ostareck, D.; et al. Deep and accurate detection of m6A RNA modifications using miCLIP2 and m6Aboost machine learning. Nucleic Acids Res. 2021, 49, e92. [Google Scholar] [CrossRef]
- Wang, Y.; Wang, J.; Li, X.; Xiong, X.; Wang, J.; Zhou, Z.; Zhu, X.; Gu, Y.; Dominissini, D.; He, L.; et al. N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat. Commun. 2021, 12, 6314. [Google Scholar] [CrossRef]
- Meyer, K.D.; Saletore, Y.; Zumbo, P.; Elemento, O.; Mason, C.E.; Jaffrey, S.R. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell 2012, 149, 1635–1646. [Google Scholar] [CrossRef] [Green Version]
- Shen, G.; Shen, H.; Zhang, J.; Yan, Q.; Liu, H. DNA methylation in Hepatoblastoma-a literature review. Ital. J. Pediatr. 2020, 46, 113. [Google Scholar] [CrossRef]
- Zhang, W.; Meyfeldt, J.; Wang, H.; Kulkarni, S.; Lu, J.; Mandel, J.A.; Marburger, B.; Liu, Y.; Gorka, J.E.; Ranganathan, S.; et al. beta-Catenin mutations as determinants of hepatoblastoma phenotypes in mice. J. Biol. Chem. 2019, 294, 17524–17542. [Google Scholar] [CrossRef]
- Sha, Y.L.; Liu, S.; Yan, W.W.; Dong, B. Wnt/beta-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci. Rep. 2019, 39, BSR20192466. [Google Scholar] [CrossRef]
- Chen, H.; Duan, F.; Wang, M.; Zhu, J.; Zhang, J.; Cheng, J.; Li, L.; Li, S.; Li, Y.; Yang, Z.; et al. Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study. Gene 2021, 800, 145834. [Google Scholar] [CrossRef]
- Czauderna, P.; Garnier, H. Hepatoblastoma: Current understanding, recent advances, and controversies. F1000Res 2018, 7, 53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Czauderna, C.; Poplawski, A.; O’Rourke, C.J.; Castven, D.; Perez-Aguilar, B.; Becker, D.; Heilmann-Heimbach, S.; Odenthal, M.; Amer, W.; Schmiel, M.; et al. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight 2021, 6, 146196. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.; Li, Y.; Li, L.; Zhu, J.; Yang, Z.; Zhang, J.; Li, S.; Xin, Y.; Xia, H.; He, J. YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study. J. Gene Med. 2020, 22, e3249. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Peng, C.; Chen, J.; Chen, D.; Yang, B.; He, B.; Hu, W.; Zhang, Y.; Liu, H.; Dai, L.; et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol. Cancer 2019, 18, 127. [Google Scholar] [CrossRef] [Green Version]
- Spector, D.L.; Lamond, A.I. Nuclear speckles. Cold Spring Harb. Perspect. Biol. 2011, 3, 646. [Google Scholar] [CrossRef] [Green Version]
- Little, N.A.; Hastie, N.D.; Davies, R.C. Identification of WTAP, a novel Wilms’ tumour 1-associating protein. Hum. Mol. Genet. 2000, 9, 2231–2239. [Google Scholar] [CrossRef] [Green Version]
- Li, J.; Xie, H.; Ying, Y.; Chen, H.; Yan, H.; He, L.; Xu, M.; Xu, X.; Liang, Z.; Liu, B.; et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Mol. Cancer 2020, 19, 152. [Google Scholar] [CrossRef]
- Sergi, C.M. Pathology of Childhood and Adolescence: An Illustrated Guide, 1st ed.; Springer: Berlin-Heidelberg, Germany, 2020; p. 1617. [Google Scholar]
- An, Y.; Duan, H. The role of m6A RNA methylation in cancer metabolism. Mol. Cancer 2022, 21, 14. [Google Scholar] [CrossRef]
- Qu, Y.; Dang, S.; Hou, P. Gene methylation in gastric cancer. Clin. Chim. Acta 2013, 424, 53–65. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Zhang, T.; Yin, Q.; Luo, H. Development and validation of genomic and epigenomic signatures associated with tumor immune microenvironment in hepatoblastoma. BMC Cancer 2021, 21, 1156. [Google Scholar] [CrossRef]
- Mazzoni, S.M.; Fearon, E.R. AXIN1 and AXIN2 variants in gastrointestinal cancers. Cancer Lett. 2014, 355, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Yang, Y.; Shen, F.; Huang, W.; Qin, S.; Huang, J.T.; Sergi, C.; Yuan, B.F.; Liu, S.M. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2019, 104, 665–673. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Yang, F.; Gao, M.; Gong, R.; Jin, M.; Liu, T.; Sun, Y.; Fu, Y.; Huang, Q.; Zhang, W.; et al. miR-149-3p Regulates the Switch between Adipogenic and Osteogenic Differentiation of BMSCs by Targeting FTO. Mol. Ther. Nucleic Acids 2019, 17, 590–600. [Google Scholar] [CrossRef] [Green Version]
- Zhao, N.N.; Dong, G.P.; Wu, W.; Wang, J.L.; Ullah, R.; Fu, J.F. FTO gene polymorphisms and obesity risk in Chinese population: A meta-analysis. World J. Pediatr. 2019, 15, 382–389. [Google Scholar] [CrossRef]
- Shen, F.; Huang, W.; Huang, J.T.; Xiong, J.; Yang, Y.; Wu, K.; Jia, G.F.; Chen, J.; Feng, Y.Q.; Yuan, B.F.; et al. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5. J. Clin. Endocrinol. Metab. 2015, 100, E148–E154. [Google Scholar] [CrossRef] [Green Version]
- Nagae, G.; Yamamoto, S.; Fujita, M.; Fujita, T.; Nonaka, A.; Umeda, T.; Fukuda, S.; Tatsuno, K.; Maejima, K.; Hayashi, A.; et al. Genetic and epigenetic basis of hepatoblastoma diversity. Nat. Commun. 2021, 12, 5423. [Google Scholar] [CrossRef]
- Czauderna, P. Is it worth completely resecting hepatoblastoma at diagnosis? Lancet Oncol. 2019, 20, 614–615. [Google Scholar] [CrossRef]
- Aronson, D.C.; Weeda, V.B.; Maibach, R.; Czauderna, P.; Dall’Igna, P.; de Ville de Goyet, J.; Branchereau, S.; Perilongo, G.; Brock, P.; Zsiros, J.; et al. Microscopically positive resection margin after hepatoblastoma resection: What is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur. J. Cancer 2019, 106, 126–132. [Google Scholar] [CrossRef]
- Carrillo-Reixach, J.; Torrens, L.; Simon-Coma, M.; Royo, L.; Domingo-Sabat, M.; Abril-Fornaguera, J.; Akers, N.; Sala, M.; Ragull, S.; Arnal, M.; et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J. Hepatol. 2020, 73, 328–341. [Google Scholar] [CrossRef]
- Huff, S.; Tiwari, S.K.; Gonzalez, G.M.; Wang, Y.; Rana, T.M. m(6)A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells. ACS Chem. Biol. 2021, 16, 324–333. [Google Scholar] [CrossRef]
- Lan, N.; Lu, Y.; Zhang, Y.; Pu, S.; Xi, H.; Nie, X.; Liu, J.; Yuan, W. FTO—A Common Genetic Basis for Obesity and Cancer. Front. Genet. 2020, 11, 559138. [Google Scholar] [CrossRef]
- Kumar, S.; Nagpal, R.; Kumar, A.; Ashraf, M.U.; Bae, Y.S. Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia. Biomedicines 2021, 9, 9060690. [Google Scholar] [CrossRef]
- Helm, M.; Motorin, Y. Detecting RNA modifications in the epitranscriptome: Predict and validate. Nat. Rev. Genet. 2017, 18, 275–291. [Google Scholar] [CrossRef]
- Li, X.; Xiong, X.; Yi, C. Epitranscriptome sequencing technologies: Decoding RNA modifications. Nat. Methods 2016, 14, 23–31. [Google Scholar] [CrossRef]
- Garalde, D.R.; Snell, E.A.; Jachimowicz, D.; Sipos, B.; Lloyd, J.H.; Bruce, M.; Pantic, N.; Admassu, T.; James, P.; Warland, A.; et al. Highly parallel direct RNA sequencing on an array of nanopores. Nat. Methods 2018, 15, 201–206. [Google Scholar] [CrossRef]
- Parker, M.T.; Knop, K.; Sherwood, A.V.; Schurch, N.J.; Mackinnon, K.; Gould, P.D.; Hall, A.J.; Barton, G.J.; Simpson, G.G. Nanopore direct RNA sequencing maps the complexity of Arabidopsis mRNA processing and m(6)A modification. Elife 2020, 9, 49658. [Google Scholar] [CrossRef]
- Xu, L.; Seki, M. Recent advances in the detection of base modifications using the Nanopore sequencer. J. Hum. Genet. 2020, 65, 25–33. [Google Scholar] [CrossRef] [Green Version]
- Kim, D.; Lee, J.Y.; Yang, J.S.; Kim, J.W.; Kim, V.N.; Chang, H. The Architecture of SARS-CoV-2 Transcriptome. Cell 2020, 181, 914–921.e910. [Google Scholar] [CrossRef]
- Pratanwanich, P.N.; Yao, F.; Chen, Y.; Koh, C.W.Q.; Wan, Y.K.; Hendra, C.; Poon, P.; Goh, Y.T.; Yap, P.M.L.; Chooi, J.Y.; et al. Identification of differential RNA modifications from nanopore direct RNA sequencing with xPore. Nat. Biotechnol. 2021, 39, 1394–1402. [Google Scholar] [CrossRef]
- Leger, A.; Amaral, P.P.; Pandolfini, L.; Capitanchik, C.; Capraro, F.; Miano, V.; Migliori, V.; Toolan-Kerr, P.; Sideri, T.; Enright, A.J.; et al. RNA modifications detection by comparative Nanopore direct RNA sequencing. Nat. Commun. 2021, 12, 7198. [Google Scholar] [CrossRef]
- Workman, R.E.; Tang, A.D.; Tang, P.S.; Jain, M.; Tyson, J.R.; Razaghi, R.; Zuzarte, P.C.; Gilpatrick, T.; Payne, A.; Quick, J.; et al. Nanopore native RNA sequencing of a human poly(A) transcriptome. Nat. Methods 2019, 16, 1297–1305. [Google Scholar] [CrossRef] [PubMed]
- Lorenz, D.A.; Sathe, S.; Einstein, J.M.; Yeo, G.W. Direct RNA sequencing enables m(6)A detection in endogenous transcript isoforms at base-specific resolution. RNA 2020, 26, 19–28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jenjaroenpun, P.; Wongsurawat, T.; Wadley, T.D.; Wassenaar, T.M.; Liu, J.; Dai, Q.; Wanchai, V.; Akel, N.S.; Jamshidi-Parsian, A.; Franco, A.T.; et al. Decoding the epitranscriptional landscape from native RNA sequences. Nucleic Acids Res. 2021, 49, e7. [Google Scholar] [CrossRef] [PubMed]
- Jenjaroenpun, P.; Wanchai, V.; Ono-Moore, K.D.; Laudadio, J.; James, L.P.; Adams, S.H.; Prior, F.; Nookaew, I.; Ussery, D.W.; Wongsurawat, T. Two SARS-CoV-2 Genome Sequences of Isolates from Rural U.S. Patients Harboring the D614G Mutation, Obtained Using Nanopore Sequencing. Microbiol. Resour. Announc. 2020, 10, e01109–e01120. [Google Scholar] [CrossRef]
- Jenjaroenpun, P.; Wongsurawat, T.; Udaondo, Z.; Anderson, C.; Lopez, J.; Mohan, M.; Tytarenko, R.; Walker, B.; Nookaew, I.; Ussery, D.; et al. Complete Genome Sequences of Four Isolates of Vancomycin-Resistant Enterococcus faecium with the vanA Gene and Two Daptomycin Resistance Mutations, Obtained from Two Inpatients with Prolonged Bacteremia. Microbiol. Resour. Announc. 2020, 9, e01380–e01419. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Auld, F.M.; Sergi, C.M.; Leng, R.; Shen, F. The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review. Cells 2022, 11, 1516. https://doi.org/10.3390/cells11091516
Auld FM, Sergi CM, Leng R, Shen F. The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review. Cells. 2022; 11(9):1516. https://doi.org/10.3390/cells11091516
Chicago/Turabian StyleAuld, Finn Morgan, Consolato M. Sergi, Roger Leng, and Fan Shen. 2022. "The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review" Cells 11, no. 9: 1516. https://doi.org/10.3390/cells11091516